Physician

Kumari Usha, MD

According to 2025 Medicare claims, Kumari Usha, MD (NPI: 1861443020) practices nephrology in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is BANNER HEALTH PHYSICIANS WEST LLC (NPI: 1063778728; TIN: 900733283) and primary practice location at 82601-2951.

Usha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 601 traditional Medicare patients, billed 2,207 HCPCS/CPT codes, and received $257,524 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,051 prescription claims across 356 beneficiaries totaling $497,080 in drug costs, led by Jynarque (Tolvaptan). DME data shows 121 claims. Open Payments data shows 2 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $166,842 and ending at $257,524. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	430	2,699	$166,842
2016	360	2,248	$149,280
2017	345	2,300	$178,182
2018	405	2,604	$161,210
2019	384	2,122	$144,165
2020	325	2,172	$144,499
2021	347	2,719	$189,277
2022	335	1,499	$131,574
2023	537	1,812	$260,965
2024	601	2,207	$257,524

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	320	3,167	$396,314
2016	311	2,997	$395,457
2017	308	3,169	$457,568
2018	313	2,945	$263,525
2019	307	2,355	$201,581
2020	302	2,643	$194,099
2021	333	3,003	$245,296
2022	356	3,007	$362,316
2023	392	1,970	$424,101
2024	356	2,051	$497,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	71	$5,163
2024	N/R	121	$2,865

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	238	345	$136
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	78	78	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	273	383	$98
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	132	272	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	119	284	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jynarque	Tolvaptan	15	420	$296,755
Jardiance	Empagliflozin	32	1,745	$33,979
Farxiga	Dapagliflozin Propanediol	27	1,025	$20,062
Renvela	Sevelamer Carbonate	18	644	$17,485
Trulicity	Dulaglutide	13	364	$12,152

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	29	$1,744
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	28	$527
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	34	$426
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$153
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	19	$14

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$122	Outset Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kumari Usha, MD?

Tedicare shows public-source Medicare data for Kumari Usha, MD (NPI 1861443020), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kumari Usha, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kumari Usha, MD?

Kumari Usha, MD is linked to BANNER HEALTH PHYSICIANS WEST LLC (billing NPI 1063778728) in the available physician profile data.

Does Kumari Usha, MD have Open Payments data?

Kumari Usha, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.